ArticleHuman vaccines & immunotherapeutics2026
Perceived risk and time costs as correlates of hepatitis vaccine hesitancy among Chinese university students: A ten‑university cross‑sectional study.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To estimate the prevalence of hepatitis vaccine hesitancy among Chinese university students and identify modifiable correlates to guide campus programs. We ran a multicampus cross-sectional survey (December 2023-February 2024) using a two-stage stratified cluster design across eastern, central, and western China. Hesitancy was measured with an 11 item hepatitis-adapted Vaccine Hesitancy Scale (α = 0.83). Multivariable logistic regression examined Health Belief Model constructs and convenience (travel/visit time). Among 2526 respondents, 51.8% met the prespecified hesitancy threshold. Seniors were more hesitant than juniors (aOR = 1.55, 95% CI: 1.25-1.91); students in the central region exceeded those in the east (1.30, 1.07-1.59). Off-campus residence (0.58, 0.41-0.83) and non-medical majors (0.68, 0.54-0.85) had lower odds. Higher perceived risk was also associated with lower hesitancy (0.66, 0.55-0.78). Ordering takeout showed a dose - response (e.g. 3-4/week vs never: 2.52, 1.67-3.82), whereas sharing tableware/drinkware was inversely associated (e.g., 3-4/week vs never: 0.38, 0.23-0.63). Time costs mattered: travel time >30 minutes was linked to higher hesitancy (1.43, 1.06-1.94), and unclear visit duration was also associated (1.40, 1.02-1.93). Hepatitis vaccine hesitancy is common among university students. Two modifiable levers - risk perception and service convenience - support highyield campus strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.